Related Experiment Videos
[Profibrotic effects of aldosterone].
A H Van Den Meiracker1, A T M Huizenga, F Boomsma
1Erasmus Medisch Centrum, afd. Interne Geneeskunde, dr.Molewaterplein 40, 30o5 GD Rotterdam. a.vandenmeiracker@erasmusmc.nl
Nederlands Tijdschrift Voor Geneeskunde
|September 16, 2004
Summary
Aldosterone promotes cardiac fibrosis and kidney damage by activating mineralocorticoid receptors. Aldosterone receptor antagonists may offer benefits in heart failure patients.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Context:
- Aldosterone's role in cardiac fibrosis and renal nephrosclerosis is established in animal models.
- Mineralocorticoid receptors and the activating enzyme 11beta-hydroxysteroid-dehydrogenase type 2 are present in the human heart.
Purpose:
- To explore the profibrotic effects of aldosterone in human cardiovascular and renal systems.
- To investigate the clinical implications of aldosterone receptor antagonism in heart failure and primary hyperaldosteronism.
Summary:
- High sodium intake and aldosterone activate mineralocorticoid receptors, leading to cardiac fibrosis and renal nephrosclerosis.
- In humans, aldosterone's profibrotic effects are linked to diastolic dysfunction, arrhythmia, and worsening heart and kidney failure.
- Aldosterone receptor antagonists improve outcomes in heart failure by reducing collagen turnover and cardiac events.
Impact:
- Aldosterone receptor antagonists show promise in managing heart failure and related cardiac complications.
- Further research is needed to clarify aldosterone's profibrotic role in primary hyperaldosteronism and the antifibrotic potential of antagonists in renal impairment.